Study at a glance
How do cells break down vitamin D?
The review examines how cells break down vitamin D compounds and limit their effects. It focuses on CYP24A1, an enzyme that changes both 25-hydroxyvitamin D, the starting compound for activation, and active vitamin D itself. The enzyme carries out several chemical steps, which can follow different routes and produce different compounds.
What did experiments show about vitamin D breakdown?
Changing one building block of the human enzyme reversed its preferred chemical route in a laboratory experiment. This shows that the enzyme’s structure affects which products it makes. In mice without CYP24A1, the time taken for active vitamin D in blood to fall by half increased from roughly 6 to 60 hours. That result shows how strongly this enzyme can affect removal in mice; it is not a measured time for people.
How does active vitamin D help limit further activity?
Active vitamin D can cause many cells to make more CYP24A1. The extra enzyme then helps break down vitamin D compounds, limiting further activity. In the kidneys, hormones also coordinate breakdown with production of active vitamin D. The same controls do not necessarily apply in exactly the same way in every tissue.
Are all vitamin D breakdown products inactive?
Breakdown does not make every product immediately inactive. Some products have reported effects in the body. However, it remains unclear how they may help build tissue. Another enzyme, CYP3A4, can break down vitamin D compounds in the liver and intestine. Its importance at ordinary concentrations is uncertain because its activity is clearest at high concentrations. Overall, breakdown depends on the enzyme, the tissue and the compound being changed.
Read the full article below ↓Cellular vitamin D regulation includes an active termination system as well as activation. Jones, Prosser and Kaufmann’s review shows how CYP24A1 controls the persistence and metabolic routing of both precursor and active vitamin D metabolites, and why that role is more complex than simply “switching vitamin D off.”
CYP24A1 is a multistep catabolic enzyme
CYP24A1 accepts both 25(OH)D and 1,25(OH)2D and can direct them through C24: or C23-oxidation pathways. Repeated reactions can lead toward calcitroic acid or lactone products rather than stopping after a single hydroxylation. Structural changes can redirect pathway preference: one human Ala326Gly substitution reversed the reported C24:C23 ratio from about 8.1:1 to 1:8.3.
This matters because ‘CYP24A1 activity’ does not identify one product or one biological consequence. Product routing depends on enzyme structure, substrate orientation and species.
Negative feedback has measurable physiological scale
VDR activation strongly induces CYP24A1 in many target cells, providing a direct route by which rising 1,25(OH)2D can increase the machinery that subsequently metabolises it. In Cyp24a1-null mice, the plasma half-life of 1,25(OH)2D increased from roughly 6 hours to roughly 60 hours, showing how strongly the enzyme can determine active-hormone persistence.
Renal PTH and FGF23 regulation place this catabolic arm inside reciprocal endocrine control with CYP27B1 rather than treating degradation as an isolated reaction.
Why degradation is not a universal off switch
Reported effects of some 24-hydroxylated metabolites mean the first oxidation step cannot be equated with immediate universal biological silence, although their specific anabolic mechanism remains unresolved. CYP3A4 also metabolises vitamin D compounds in liver and intestine, but Jones questions its ordinary physiological importance because its activity is most evident at micromolar or pharmacological concentrations.
The clearest conclusion is that CYP24A1 is central to vitamin D clearance and feedback, but cellular degradation is multistep, product-specific and tissue-dependent rather than a single irreversible switch.
This catabolic arm belongs within Vitamin D Metabolism at the Cellular Level and connects directly with the wider physiology of Vitamin D Clearance and Degradation.
Primary source
Jones G, Prosser DE, Kaufmann M. Cytochrome P450-mediated metabolism of vitamin D. Journal of Lipid Research. 2014;55(1):13 to 31. Read the full paper.
The Full Evidence Review develops the structural, genetic, knockout and feedback evidence behind these conclusions.
Related reading
Cellular degradation and feedback regulation of vitamin D: Full Evidence Review
A full evidence review of cellular vitamin D degradation, CYP24A1 activity and feedback regulation controlling vitamin D metabolite availability.
Read more →Influence of Cellular Aging on Liver Stiffness in Patients With Hepatitis C Virus Achieving Sustained Viral Response
Our aim was to analyze whether the parameters associated with cellular aging measured at the DAA initiation date are related to LS reduction upon achieving SVR.
Original paper ↗Read more →Safety and Humoral and Cellular Immunogenicity of the BNT162b2 SARS-CoV-2 Vaccine in Liver-Transplanted Adolescents Compared to Healthy Adolescents
Since BNT162b2 was approved to prevent COVID-19 in children, we aim to compare the safety and immunogenicity of the BNT162b2 vaccine in liver-transplanted (LT) and healthy adolescents.
Original paper ↗Read more →Vitamin D suppresses cellular pathways of diabetes complication in liver
The aim of this study was to investigate the effect of vitamin D on glucose metabolism, as well as the expression of five key genes involved in the development of diabetes complications in liver tissue of diabetic rats.
Original paper ↗Read more →Association of longitudinal serum 25-hydroxyvitamin D trajectories with subsequent liver stiffness increase in patients with early-onset type 2 diabetes and metabolic dysfunction-associated steatotic liver disease
We evaluated the associations of longitudinal 25(OH)D trajectories with subsequent liver stiffness measurement (LSM) increases in patients with early-onset type 2 diabetes and metabolic dysfunction-associated steatotic liver disease.
Original paper ↗Read more →Correlation of Vitamin 25(OH)D, Liver Enzymes, Potassium, and Oxidative Stress Markers with Lipid Profile and Atheromatic Index: A Pilot Study
This study aims to investigate the correlation of lipid profile and atheromatic index TC/HDL with several biomarkers and oxidative stress parameters.
Original paper ↗Read more →Correlational study on the levels of 25-hydroxyvitamin D and non-alcoholic fatty liver disease in type 2 diabetic patients
The objective of this study is to retrospectively probe the association between the 25-hydroxyvitamin D (25-(OH)D) and NAFLD in type 2 diabetic patients.
Original paper ↗Read more →Disrupted Vitamin D Metabolism in Hepatocellular Carcinoma: Free and Bioavailable 25(OH)D as Novel Biomarkers of Hepatic Reserve and Clinical Risk
Correlations with Child: Pugh score, Barcelona Clinic Liver Cancer (BCLC) stage, and disease aetiology were evaluated.
Original paper ↗Read more →Effects of an Eight Week Very Low-Calorie Ketogenic Diet (VLCKD) on White Blood Cell and Platelet Counts in Relation to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Subjects with Overweight and Obesity
We evaluated the efficacy of 8 weeks’ VLCKD in decreasing the white blood cell (WBC) and platelet (PLT) counts, as well as liver steatosis and fibrosis, diagnosed using transient elastography (FibroScan).
Original paper ↗Read more →Higher Serum 25-Hydroxyvitamin D Is Associated with Lower All-Cause and Cardiovascular Mortality among US Adults with Nonalcoholic Fatty Liver Disease
Aims: We aimed to assess the association between serum 25-hydroxyvitamin D (25(OH)D) levels with all-cause and cardiovascular mortality in patients with nonalcoholic fatty liver disease (NAFLD).
Original paper ↗Read more →Incidence of malnutrition and changes in phosphocalcic metabolism in perioperative liver transplantation patients: a retrospective study in a tertiary children’s hospital in China
The primary aim of the study was to assess the nutritional status of pediatric liver transplant outpatients in nutrition clinic, particularly the nutritional status of their bones.
Original paper ↗Read more →Liver Graft Pathology and Low Serum 25-Hydroxyvitamin D after Living Donor Liver Transplantation
Aims: We conducted this study to explore the interplay between VDR and CYP2R1 in liver graft and compared our findings with the pathological interpretation of serum 25(OH)D concentration.
Original paper ↗Read more →Low Serum 25-Hydroxyvitamin D Levels Are Related to Frailty and Sarcopenia in Patients with Chronic Liver Disease
This study aimed at exploring the relationship between serum 25-hydroxyvitamin D [25(OH)D] levels and frailty or sarcopenia in 231 patients with CLD.
Original paper ↗Read more →Relationship between non-alcoholic fatty liver and progressive fibrosis and serum 25-hydroxy vitamin D in patients with type 2 diabetes mellitus
We aimed to analyze the relationship between non-alcoholic fatty liver and progressive fibrosis and serum 25-hydroxy vitamin D (25(OH)D) in patients with type 2 diabetes mellitus.
Original paper ↗Read more →Relationship of Vitamin D Deficiency and Fatty Liver in Children as Defined by Multiple Imaging and Histologic Endpoints
All participants had liver imaging, namely, controlled attenuation parameter to assess steatosis and, to assess fibrosis, vibration controlled transient elastography (FibroScan), and acoustic radiation force impulse imaging.
Original paper ↗Read more →Seasonal Variation in 25(OH)D at Aberdeen (57°N) and Bone Health Indicators: Could Holidays in the Sun and Cod Liver Oil Supplements Alleviate Deficiency?
The aim of this longitudinal study, was to assess predictors of seasonal variation of 25-hydroxy-vitamin D (25(OH)D) (including use of supplements and holidays in sunny destinations) at a northerly latitude in the UK (57°N) in relation to bone health indicators.
Original paper ↗Read more →Temporal trend of serum vitamin profiles and the association with non-alcoholic fatty liver disease
This study aimed to characterize temporal trends of serum vitamins (A, B9, B12, D, E) among Chinese adults undergoing health examinations (2015 to 2023) and explore their associations with NAFLD.
Original paper ↗Read more →The Role of Vitamin D and Vitamin D Binding Protein in Chronic Liver Diseases
Vitamin D (calciferol) is a fat-soluble vitamin that has a significant role in phospho-calcium metabolism, maintaining normal calcium levels and bone health development.
Original paper ↗Read more →Vitamin D receptor ApaI polymorphism associated with progression of liver disease in Vietnamese patients chronically infected with hepatitis B virus
In the recessive model, the genotype ApaI AA was found more frequently among HCC compared to CHB patients (OR = 2.56, 95%CI = 1.01 to 6.48, P = 0.04).
Original paper ↗Read more →Vitamin D Supplementation and Non-Alcoholic Fatty Liver Disease: Present and Future
The aim of this review is to give an overview of the evidence currently available from clinical trials and to discuss possible shortcomings and new strategies to be considered in future investigations.
Original paper ↗Read more →Liver Disease, Carrier Proteins and Vitamin D Availability: Full Study
How liver disease changes vitamin D interpretation: biopsy findings, carrier proteins, free and total measurements, and limits of treatment claims.
Read more →Original sources
Read the full paper
Jones G, Prosser DE, Kaufmann M.
Publication details
Jones G, Prosser DE, Kaufmann M. Cytochrome P450-mediated metabolism of vitamin D. Journal of Lipid Research. 2014;55(1):13 to 31. Read the full paper.